Exchange Traded Concepts LLC Has $71,000 Stake in Blueprint Medicines Co. (NASDAQ:BPMC)

Exchange Traded Concepts LLC increased its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) by 51.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 661 shares of the biotechnology company’s stock after acquiring an additional 225 shares during […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,United States ,America ,Brian Druker ,Mark Alan Goldberg ,Ariel Hurley ,Chris Varma ,Nicholasb Lydon ,Eagle Health Investments ,Morgan Stanley ,Securities Exchange Commission ,Exchange Traded Concepts ,America Corp ,Nasdaq ,Marshall Wace ,Blueprint Medicines Corp ,Blueprint Medicines Co ,Blueprint Medicines Company Profile Get Rating ,Citigroup ,Blueprint Medicines ,Get Rating ,Traded Concepts ,Health Investments ,Exchange Commission ,Director Mark Alan Goldberg ,Medicines Company Profile ,Alexis Borisy ,Visit Holdingschannel ,Nasdaq Bpmc ,Bpmc ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,